Sillajen – South Korea

Last updated: 24.03.2015

Sillajen LogoSillaJen, Inc. is a privately-held biotechnology company focusing on engineering and developing best-in-class oncolytic immunotherapeutics. SillaJen has Korean offices in Busan (R&D), at Pusan National University (PNU), and in Seoul (finance, management & legal). SillaJen also has Clinical R&D, regulatory affairs and CMC capabilities in San Francisco, California, one of the world’s leading biotechnology centers and the “birthplace” of the biotech industry. SillaJen products are engineered from vaccinia which has unique attributes as an oncolytic immunotherapy.

Contact Details
Busan Office

Seoul Office

San Francisco Office



We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here